v3.26.1
Consolidated Statements of Changes in Stockholder's Deficit - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2023 [1] $ 1,750 $ 9,323,403 $ (25,118,907) $ (15,793,754)
Beginning balance (in shares) at Dec. 31, 2023 [1] 17,500,000      
Net loss     (3,546,309) (3,546,309)
Ending balance at Dec. 31, 2024 [1],[2] $ 1,750 9,323,403 (28,665,216) $ (19,340,063)
Ending balance (in shares) at Dec. 31, 2024 17,500,000 [1],[2]     17,500,000
Net loss     (327,526) $ (327,526)
Ending balance at Mar. 31, 2025 $ 1,750 9,323,403 (28,992,742) (19,667,589)
Ending balance (in shares) at Mar. 31, 2025 17,500,000      
Beginning balance at Dec. 31, 2024 [1],[2] $ 1,750 9,323,403 (28,665,216) $ (19,340,063)
Beginning balance (in shares) at Dec. 31, 2024 17,500,000 [1],[2]     17,500,000
Business combination with IRIS, net of transaction costs $ 11 190,379   $ 190,390
Business combination with IRIS, net of transaction costs (in shares) 114,633      
Settlement of loans to Iris Acquisition Corp upon closing of the business combination   (4,443,500)   (4,443,500)
Issuance of common stock to Iris Acquisition Holdings, LLC $ 690 (690)    
Issuance of common stock to Iris Acquisition Holdings, LLC (in shares) 6,900,000      
Issuance of common stock for the PIPE investment $ 150 14,999,850   15,000,000
Issuance of common stock in connection with the Offering, net of offering costs of $559,962 (in shares) 1,500,000      
Issuance of common stock to underwriter $ 70 7,244,930   7,245,000
Issuance of common stock to underwriter (In shares) 700,000      
Issuance of common stock in connection with the surrender of warrants $ 35 1,739,965   1,740,000
Issuance of common stock in connection with the surrender of warrants (in shares) 350,000      
Net loss     (10,206,517) (10,206,517)
Ending balance at Dec. 31, 2025 [2] $ 2,706 29,054,337 (38,871,733) $ (9,814,690)
Ending balance (in shares) at Dec. 31, 2025 27,064,633 [2]     27,064,633
Issuance of common stock for the PIPE investment $ 1,381 3,444,427   $ 3,445,808
Issuance of common stock in connection with the Offering, net of offering costs of $559,962 (in shares) 13,813,000      
Net loss     (1,123,714) (1,123,714)
Ending balance at Mar. 31, 2026 $ 4,823 $ 39,858,028 $ (39,995,447) $ (132,596)
Ending balance (in shares) at Mar. 31, 2026 44,877,633     44,877,633
[1] Shares, preferred stock amount, common stock amount and additional paid-in capital data are presented on a retroactive basis to reflect the effects of the conversion and recapitalization as a result of the Business Combination consummated on April 30, 2025.
[2] Shares, preferred stock amount, common stock amount and additional paid - in capital data are presented on a retroactive basis to reflect the effects of the conversion and recapitalization as a result of the Business Combination consummated on April 30, 2025.